Myers’ Cocktail IV Therapy for Brain Health
The Myers’ Cocktail delivers magnesium, calcium, B vitamins, and vitamin C directly into the bloodstream, bypassing intestinal absorption limits to reach the serum concentrations required for neuronal enzyme function. At The Neurogenesis Project, Dr. Sean Orr uses this formulation as part of the neuronutrient protocol within the Intensive Brain Health Program.
The Formulation and Its Neurological Rationale
The Myers’ Cocktail was developed in the 1960s by Baltimore physician John Myers, who administered intravenous nutrient infusions to patients with a range of chronic conditions. After Myers’ death, Alan Gaby continued the protocol and published a clinical review in Alternative Medicine Review (2002) documenting its use across more than 15,000 infusions. The formulation persists in clinical practice because each of its components serves as a cofactor or substrate in well-characterized neurobiological pathways.
The brain consumes roughly 20 percent of the body’s metabolic energy despite comprising only 2 percent of body mass. This disproportionate metabolic demand means that even modest deficiencies in the vitamins and minerals that drive mitochondrial electron transport, neurotransmitter synthesis, and ion channel function can produce measurable cognitive and neurological symptoms. Oral supplementation addresses mild deficiencies, but patients with malabsorption, high metabolic demand, or acute neurological conditions often require the higher serum concentrations that only intravenous delivery can achieve.
Components and Their Roles in the Nervous System
Magnesium
Magnesium is a cofactor in over 300 enzymatic reactions, and its neurological significance centers on its role as a voltage-dependent blocker of the NMDA receptor ion channel. Under resting conditions, magnesium ions sit in the NMDA receptor pore and prevent calcium influx. When the postsynaptic membrane depolarizes sufficiently, the magnesium block is relieved and calcium enters, initiating the intracellular signaling cascades that underlie synaptic plasticity. When systemic magnesium is low, this gating mechanism becomes dysregulated, and neurons become more susceptible to excitotoxic damage.
Gröber et al. published a comprehensive review in Nutrients (2017) examining magnesium’s role in neurological disorders, documenting associations between hypomagnesemia and migraine, depression, epilepsy, and Alzheimer’s disease. Mauskop and Varughese (2012, Journal of Neural Transmission) reported that intravenous magnesium sulfate provided acute migraine relief in patients with documented low ionized magnesium levels, with response rates exceeding 85 percent in the hypomagnesemic subgroup. In our clinic, magnesium status is assessed before treatment, and the infusion dose is calibrated accordingly.
B Vitamins
The B vitamin complex participates in nearly every aspect of neural metabolism. Kennedy (2016, Nutrients) reviewed the evidence linking B vitamin status to brain function and identified specific roles for each member of the complex:
- Thiamine (B1) is the cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, two rate-limiting enzymes in the citric acid cycle. Thiamine deficiency impairs neuronal energy production and, in its severe form (Wernicke encephalopathy), causes acute confusional states with characteristic lesions in the mammillary bodies and periventricular gray matter.
- Riboflavin (B2) and Niacinamide (B3) are precursors to FAD and NAD+, the electron carriers that drive oxidative phosphorylation in neuronal mitochondria. Without adequate B2 and B3, mitochondrial ATP output declines, and neurons become vulnerable to energy failure under metabolic stress.
- Pantothenic Acid (B5) is required for the synthesis of coenzyme A, which mediates acetyl group transfers in the citric acid cycle and is essential for the synthesis of acetylcholine, the neurotransmitter that drives cholinergic circuits involved in memory, attention, and autonomic regulation.
- Pyridoxine (B6) is the cofactor for aromatic L-amino acid decarboxylase and glutamic acid decarboxylase, the enzymes that synthesize serotonin, dopamine, and GABA from their amino acid precursors. B6 deficiency directly reduces the production of these three neurotransmitters, contributing to mood instability, impaired impulse control, and increased neuronal excitability.
- Methylcobalamin (B12) is required for the methylation of homocysteine to methionine, a reaction that regenerates S-adenosylmethionine (SAMe), the principal methyl donor in the central nervous system. SAMe is necessary for myelin synthesis, monoamine neurotransmitter metabolism, and DNA methylation in neurons. Prolonged B12 deficiency causes subacute combined degeneration of the spinal cord and peripheral neuropathy. Even subclinical deficiency is associated with white matter changes on MRI and accelerated cognitive decline in older adults.
Vitamin C (Ascorbic Acid)
Vitamin C reaches concentrations in cerebrospinal fluid that are ten times higher than those in plasma, reflecting active transport across the blood-brain barrier via SVCT2 sodium-dependent transporters. In the brain, ascorbic acid serves as an electron donor for dopamine beta-hydroxylase, the enzyme that converts dopamine to norepinephrine. It also functions as the primary aqueous-phase antioxidant, scavenging reactive oxygen species generated by the high rate of oxidative metabolism in neural tissue. Harrison and May (2009, Free Radical Biology and Medicine) documented that vitamin C depletion impairs both catecholamine synthesis and antioxidant defense in brain tissue, with functional consequences for attention, processing speed, and mood regulation.
Calcium
Calcium ions are the trigger for synaptic vesicle fusion and neurotransmitter release at the presynaptic terminal. When an action potential reaches the axon terminal, voltage-gated calcium channels open, calcium enters, and the resulting calcium-sensor protein activation causes vesicles to fuse with the presynaptic membrane and release their neurotransmitter contents into the synaptic cleft. Calcium also activates calmodulin-dependent protein kinase II (CaMKII), a central mediator of long-term potentiation, the cellular mechanism of learning and memory. The calcium in the Myers’ Cocktail supports these signaling processes and is included at concentrations that complement, rather than compete with, the magnesium component.
Clinical Applications
The Myers’ Cocktail addresses nutrient-dependent pathways that are commonly impaired across a range of neurological and neurocognitive conditions seen at our clinic.
Migraine Prevention
Magnesium deficiency is present in up to 50 percent of migraine patients. Mauskop and Varughese (2012) demonstrated that IV magnesium reduces migraine frequency and severity, particularly in patients with aura. Riboflavin has independent evidence for migraine prophylaxis, with a 2004 randomized trial by Schoenen et al. (Neurology, n=55) showing a 50 percent reduction in attack frequency at 400 mg daily. The Myers’ Cocktail delivers both in a single infusion.
Cognitive Fatigue
Persistent mental fatigue often reflects impaired mitochondrial energy production in cortical neurons. B1, B2, and B3 are direct cofactors in the electron transport chain, and their deficiency reduces ATP yield per glucose molecule. IV repletion restores cofactor availability at the mitochondrial level more rapidly than oral supplementation, which is particularly relevant for patients whose fatigue has not responded to standard oral vitamin regimens.
Post-TBI Nutritional Support
Traumatic brain injury increases metabolic demand in the injured brain while simultaneously impairing appetite and gastrointestinal function. The post-TBI brain consumes micronutrients at accelerated rates to support repair processes, and oral intake often fails to keep pace. IV delivery ensures that the cofactors needed for neurotransmitter resynthesis, antioxidant defense, and energy metabolism reach therapeutic levels during the recovery window.
Neurodegenerative Risk Reduction
Elevated homocysteine is an independent risk factor for Alzheimer’s disease and vascular dementia. B12, B6, and folate are the cofactors that metabolize homocysteine, and Smith et al. (2010, PLoS ONE, n=168) showed that B vitamin supplementation slowed brain atrophy by 30 percent over two years in older adults with mild cognitive impairment and elevated homocysteine. The Myers’ Cocktail provides B12 and B6 at concentrations that support this methylation pathway.
Addiction Recovery Repletion
Chronic alcohol and substance use deplete B vitamins, magnesium, and vitamin C through a combination of poor dietary intake, impaired absorption, and accelerated urinary excretion. Dr. Drew Edwards works with patients in early recovery whose neurotransmitter synthesis capacity is compromised by these deficiencies. Restoring B6 levels directly supports serotonin and dopamine production, while magnesium repletion stabilizes neuronal excitability during the withdrawal and early recovery period.
Oxidative Stress Reduction
Neural tissue is particularly vulnerable to oxidative damage due to its high oxygen consumption and lipid-rich composition. Vitamin C and magnesium both contribute to antioxidant defense: ascorbic acid scavenges reactive oxygen species directly, while magnesium supports glutathione synthesis and reduces superoxide generation at the mitochondrial level. Patients with biomarker evidence of elevated oxidative stress receive the Myers’ Cocktail as part of a broader antioxidant strategy that may include glutathione IV therapy.
How the Myers’ Cocktail Fits Into Our Protocol
At The Neurogenesis Project, the Myers’ Cocktail is not prescribed in isolation. Dr. Orr orders baseline laboratory panels that include serum magnesium (and, when indicated, RBC magnesium), B12, methylmalonic acid, homocysteine, and vitamin C levels. These results, combined with neurocognitive testing and clinical assessment, determine whether nutrient repletion is indicated and at what dosing.
Within the Intensive Brain Health Program, the Myers’ Cocktail typically serves as a foundational infusion administered early in the treatment sequence. The rationale is biochemical: many of the enzymes involved in NAD+ metabolism, glutathione recycling, and neurotransmitter synthesis require B vitamins and magnesium as cofactors. Optimizing these cofactors first ensures that subsequent interventions, such as NAD+ IV therapy and glutathione infusions, have the enzymatic infrastructure they need to produce their intended effects.
For patients in addiction recovery, Dr. Edwards coordinates the nutritional protocol with behavioral and neurocoaching interventions. The neurochemical deficits created by chronic substance use respond to nutrient repletion, but repletion alone is insufficient. It provides the substrate; the coaching and behavioral work provides the framework for sustained recovery.
Follow-up labs after the treatment course document changes in nutrient levels and inflammatory markers, allowing Dr. Orr to adjust the maintenance schedule based on objective data rather than symptoms alone.
Related Treatments
NAD+ IV Therapy
Intravenous NAD+ restores mitochondrial energy metabolism and activates sirtuins involved in DNA repair. The Myers’ Cocktail provides the B vitamin cofactors that NAD+ synthesis depends on.
Glutathione IV Therapy
Glutathione is the brain’s primary intracellular antioxidant. Its recycling from oxidized to reduced form requires riboflavin-derived FAD as a cofactor, linking glutathione efficacy directly to B2 status.
Frequently Asked Questions
What is in a Myers' Cocktail?+
Why is IV delivery preferred over oral supplementation?+
How often do patients receive Myers' Cocktail infusions?+
Are there side effects?+
Does insurance cover Myers' Cocktail IV therapy?+
How does the Myers' Cocktail differ from other IV therapies offered at the clinic?+
Optimize the Foundation Your Brain Runs On
Dr. Orr evaluates every patient’s nutrient status with laboratory testing before recommending IV therapy. A consultation determines whether the Myers’ Cocktail, alone or as part of the Intensive Brain Health Program, is appropriate for your clinical situation.